GRAIL
Developer of Galleri and targeted methylation tools for cancer detection.
$80.00
After-hours close−0.01 (−0.01%)
At close$80.01(−3.02%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 96.23%41.30M sharesInsiders 3.54%1.52M sharesOther 0.23%97.6K shares
Shares outstanding 42.92M · Float 39.29M · 91.6% free float
Institutions13F, as of Jun 30, 2026
391 holders · 41.30M shares · 66 new positions · 180 increased · 101 reduced · 58 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Farallon Capital Management LLC | 4.16M | 9.70% | +907.9K | Aug 14, 2026 |
| Baker Bros. Advisors LP | 4.03M | 9.39% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 3.58M | 8.33% | +608.5K | Aug 7, 2026 |
| State Street Corp | 2.39M | 5.56% | +493.6K | Aug 7, 2026 |
| Primecap Management Co/CA/ | 2.18M | 5.08% | +336.3K | Aug 14, 2026 |
| Sessa Capital Im, L.P. | 2.04M | 4.75% | +318.2K | Aug 14, 2026 |
| Deep Track Capital, LP | 1.83M | 4.28% | +112.1K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.64M | 3.82% | +114.0K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 9.80% | 4.03M | 13G | May 15, 2026 ↗ |
| Sessa Capital IM, L.P.incl. John Petry, Capital (Master), L.P. +2 more | 9.66% | 3.00M | 13G | Nov 14, 2024 ↗ |
| PRIMECAP Management Company | 7.03% | 2.18M | Nov 12, 2024 ↗ | |
| BlackRock, Inc. | 6.50% | 2.33M | 13G | Jul 17, 2025 ↗ |
| State Street Corporation | 5.60% | 2.39M | 13G | Aug 7, 2026 ↗ |
| CRCM LP | 5.00% | 1.80M | 13G | Oct 6, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Illumina, Inc. | 10 percent owner | 3.50M | 8.16% | Nov 18, 2025 |
| Ding Chun R | 10 percent owner | 3.31M | 7.70% | Jul 3, 2025 |
| Robert P. Ragusa | director, officer: Chief Executive Officer | 518.6K | 1.21% | Apr 9, 2026 |
| Joshua J. Ofman | director, officer: Chief Executive Officer | 402.3K | 0.94% | Jun 3, 2026 |
| Aaron Freidin | officer: Chief Financial Officer | 260.7K | 0.61% | Apr 9, 2026 |
| Andrew John Partridge | officer: Chief Growth Officer | 163.7K | 0.38% | Jun 5, 2026 |
| Gregory L. Summe | director | 45.7K | 0.11% | Jul 16, 2026 |
| William J. Chase | director | 43.0K | 0.10% | Jul 16, 2026 |
| Steven Mizell | director | 42.8K | 0.10% | Jul 16, 2026 |
| Sarah Krevans | director | 42.6K | 0.10% | Jun 22, 2026 |
2 ten-percent owners hold 6.81M shares by Form 4, outside the officers-and-directors figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 4, 2026 | Andrew John Partridgeofficer: Chief Growth Officer | Sale | 1,491 | $61.08 | 163,738 |
| Apr 8, 2026 | Joshua J. Ofmandirector, officer: President | Sale | 61,665 | $49.92 | 371,216 |
| Apr 8, 2026 | Robert P. Ragusadirector, officer: Chief Executive Officer | Sale | 123,502 | $49.92 | 518,582 |
| Apr 8, 2026 | Aaron Freidinofficer: Chief Financial Officer | Sale | 45,806 | $49.92 | 260,669 |
| Mar 9, 2026 | Robert P. Ragusadirector, officer: Chief Executive Officer | Sale · 2 lots | 7,461 | $47.89 | 642,084 |
| Mar 5, 2026 | Robert P. Ragusadirector, officer: Chief Executive Officer | Sale | 980 | $53.01 | 649,545 |
| Mar 9, 2026 | Joshua J. Ofmanofficer: President | Sale · 2 lots | 2,937 | $47.89 | 432,881 |
| Mar 5, 2026 | Joshua J. Ofmanofficer: President | Sale | 690 | $53.01 | 435,818 |
| Mar 9, 2026 | Aaron Freidinofficer: Chief Financial Officer | Sale · 2 lots | 2,492 | $47.89 | 306,475 |
| Mar 5, 2026 | Aaron Freidinofficer: Chief Financial Officer | Sale | 655 | $53.01 | 308,967 |
CongressHouse and Senate disclosures
Not reported.